6505--Dalfampridine SA Tablets (VA-25-00006887)

Closed Pre-Solicitation Posted

Solicitation number
36E79724Q0009
Agency
Responses due
Set-aside
No set-aside

Opportunity facts

Notice details come from SAM.gov. Updated .

About this opportunity

The Department of Veterans Affairs (VA) National Acquisition Center is conducting market research for the procurement of Dalfampridine SA Tablets, 10MG for the VA, Department of Defense (DoD), Indian Health Service (IHS), Bureau of Prisons (BOP), and Federal Health Care Center (FHCC). This procurement will result in a national mandatory requirements contract. The Government is seeking companies that can provide a unique 11-digit National Drug Code, have a letter of commitment from the manufacturer, have business-to-business agreements with the Pharmaceutical Prime Vendors, and can meet specific packaging requirements for 60-count bottles. The Government prefers a base year contract with up to 4 option years and for companies to be able to begin supply within 60 days of award.

This procurement is not set aside and is open to both large and small businesses, though small businesses must manufacture at least 50% of the product. The estimated annual usage is 18,168 bottles, and the Government is seeking to award at lower than FSS/Open Market prices based on committed volume. Companies are asked to indicate their interest and ability to meet the requirements by August 19, 2024.

Notice text

Page 2 of 2

Sources Sought Notice - National Contracts Standardization Program

The purpose of this Sources Sought Notice is for information and planning purposes only and does not constitute a solicitation. Offers are not being solicited at this time. The Government does not intend to award a contract on the basis of this request for information.

I am conducting market research for the procurement Dalfampridine SA Tablets, 10MG for the Department of Veterans Affairs (VA), Department of Defense (DoD), Indian Health Service (IHS), Bureau of Prisons (BOP), and Federal Health Care Center (FHCC). This procurement will result in a national mandatory requirements contract for the above agencies. Other companies with the same/similar product will be blocked out for ordering; therefore, it is our goal to award lower than FSS/Open Market prices on the resultant national contract based on purchases of a committed volume. These products will be awarded in the aggregate for all strengths and sizes for the base year and all option years included in the solicitation. Please provide a response to the following:

1. Is your Company able to meet the following minimum requirements:

National Drug Code (NDC): Offerors shall provide a separate and distinct eleven-digit NDC number unique to the offeror (e.g., 00012-3456-78) for each product proposed. The first five numbers of the eleven-digit NDC number for each product proposed shall identify the offeror. Additionally, the successful offeror/contractor s label with its unique NDC shall be the only label on the product. Contractors shall not affix their label over another label on the product. Does your company have a unique NDC (Labeler Code)?_____________

If the offeror is not the manufacturer of the offered items, the offeror shall submit a letter of commitment from the manufacturer to the offeror which will assure the offeror a source of supply sufficient to satisfy the Government's requirements for the contract period. Name of Manufacturer:_________________

Would you be able to provide a letter of commitment from the manufacturer of the offered drug?_____________

Pharmaceutical Prime Vendor: All Ordering Activities under the Department of Veterans Affairs and Department of Defense acquire their pharmaceutical requirements through their Pharmaceutical Prime Vendor Program (PPV). The contractor shall ensure that chargeback agreements with the PPVs have been executed with sufficient time to permit the PPVs to begin timely distribution of Government orders, if an award is made. Does your company currently have a business-to-business agreement with the PPVs?_________

d. Under NAICS code 325412, is your company size (check one):

Large Business ______

Small Business ______

e. If a small business, does your company manufacture (measure, weigh, mix, and compound) at least 50% of the product offered?_________

f. Is the offered end product U.S end-made or designated end made product?_________

g. Can your company meet the following product, bottle size and usage:

Item

Description

Package Size (Tablets per Bottle)

Total Est. Annual Usage (Bottles)

1

Dalfampridine 10MG TAB,SA

60

18,168

2 . Is your Company interested in submitting a response to a solicitation?________

3. As this is a national standardized contract, our preference is for a base plus four option years to provide our customers continuity and consistency of product by allowing long term committed purchases of your product. If interested, please indicate Base year and how many Option periods, not to exceed 4._________________

4. If an award were to be made based on the above requirements, would your company be able to begin supplying the product in the estimated quantities within 60 days of the contract award date?

______________________________________________________________________

5. If your company is not interested in participating, please respond with the reason why. This aids our market research for future procurements.

______________________________________________________________________

6. VA intends to require in the solicitation that proposed products are in unit of use package sizes for all line items (60-count bottles). VA defines unit of use package sizes as follows: Unit of use package sizes must contain a child proof closure (safety cap) and a bottle with a minimum required size of 120cc volume. The safety cap must not exceed the diameter of the bottle. The bottle must have a cylindrical body and minimum of 5.75 circumference. The bottle must fit a label with a dimension of 5.25 x 2 . The 0.5 additional space is required to keep the bar code exposed and/or allow for the display of the expiration date and lot number. Please indicate if your company can provide the products above meeting these packaging requirements.

_______________________________________________________________________

If you could provide your responses by next Monday, August 19, 2024, it would be greatly appreciated. Please contact me if you have any questions.

Files

File Type Posted
36E79724Q0009.docx DOCX document

Similar open opportunities

Opportunity Agency Set-aside Responses due
6505--Imatinib Tablets NAICS 325412 National Acquisition Center No set-aside
6505--Sacubitril/Valsartan Tablets (VA-27-00014055) NAICS 325412 National Acquisition Center No set-aside
Methylphenidate ER NAICS 325412 Medical Supply Chain No set-aside
6505--Ramipril Capsules RFP NAICS 325412 National Acquisition Center No set-aside
6505--VA Long Beach Pylarify NAICS 325412 Veterans Integrated Service Network 22 No set-aside

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity

GovTribe for Federal Contractors